Radcliffe Capital Management’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.76M Buy
623,267
+50,045
+9% +$539K 0.51% 27
2025
Q4
$6.13M Buy
573,222
+327
+0.1% +$3.49K 0.33% 52
2025
Q3
$6.07M Buy
572,895
+425,152
+288% +$4.5M 0.38% 32
2025
Q2
$1.56M Buy
+147,743
New +$1.54M 0.12% 91

Other funds holding GPAT

Radcliffe Capital Management's GPAT Position: Q1 2026 in Review

Radcliffe Capital Management increased its GP-Act III Acquisition Corp (GPAT) stake by 8.7% in Q1 2026, buying an estimated $539K and bringing the position to 623,267 shares worth $6.76M. The position accounts for 0.51% of the portfolio, ranked #27.

Radcliffe Capital Management first reported a position in GPAT in Q2 2025 and has held it in 4 quarters since. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Radcliffe Capital Management held 623,267 shares of GP-Act III Acquisition Corp worth $6.76M as of Q1 2026.
  • Radcliffe Capital Management bought 50,045 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $539K.
  • GP-Act III Acquisition Corp made up 0.51% of Radcliffe Capital Management's portfolio in Q1 2026, its #27 holding.
  • Radcliffe Capital Management first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Radcliffe Capital Management's 13F filing for Q1 2026, filed 15 May 2026.